Emergent Biosolutions partners with British Columbia to supply NARCAN nasal spray for expanded program

Emergent Biosolutions partners with British Columbia to supply NARCAN nasal spray for expanded program
Emergent Biosolutions in BC NARCAN deal

Emergent Biosolutions has entered a partnership with British Columbia to provide NARCAN nasal spray as part of the expansion of the province's Take Home Naloxone Program.

The agreement aims to enhance access to life-saving opioid overdose reversal medication throughout the region. The NARCAN nasal spray will be distributed to support British Columbia's efforts to combat the ongoing public health crisis related to opioid overdoses. Further details about the partnership can be found on Emergent Biosolutions' official website.

Emergent Biosolutions recently launched cases for NARCAN Nasal Spray to encourage wider access to overdose response tools, according to a past company statement here. The company also committed 2026 Cycle A funding to charitable organizations focused on health, scientific education, and veteran support here. These initiatives reflect Emergent's ongoing involvement in public health efforts.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.